Skip to main contentAll experts

DrMariam Louis

PRG DIR & CLIN PROF

JX-MEDICINE AT JAX

  • PRG DIR & CLIN PROF
    JX-MEDICINE AT JAX

GRANTS

  • GRANT
    A Dose-Finding, Adaptive, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Efficacy of TAK-360 in Participants with Idiopathic Hypersomnia (IH)
    Takeda Development Center Americas Inc22 Jul 2026 - 21 Jul 2031
    Active
  • GRANT
    A Randomized, Double-Blinded, Placebo-Controlled, Dose-Finding, Adaptive Trial to Evaluate the Safety, Tolerability, and Efficacy of TAK-360 in Participants with Narcolepsy without Cataplexy (NT2)
    Takeda Development Center Americas Inc10 Jun 2026 - 9 Jun 2031
    Active
  • GRANT
    Non-invasive vagal nerve stimulation and sleep
    US Department of Veterans Affairs15 Sep 2023 - 30 Sep 2025
    Expired
  • GRANT
    The purpose of this clinical proposal to inform our understanding of EFL screening in diagnosed COPD patients We aim to understand which patients have EFL, what GOLD stage and other characteristics they may have such as hypercapnia, and other agreed physiological characteristics.
    Philips Rs North America15 Nov 2018 - 18 Dec 2023
    Closed
  • GRANT
    A DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED-WITHDRAWAL, MULTICENTER STUDY OF THE EFFICACY AND SAFETY OF XYREM WITH..
    Jazz Pharmaceuticals26 Mar 2015 - 25 Mar 2018
    Closed